Skip to content
  • ABOUT
        • MISSION/HISTORY
        • DIRECTORS/STAFF
        • SUPPORT
        • INTERNSHIPS
        • FINANCIAL INFORMATION
        • JOBS
        • CONTACT US
  • WASTEWATCHER
  • MEDIA
        • COMMENTARY
        • PRESS RELEASES
        • VIDEOS
  • ISSUES
    • CONGRESSIONAL PIG BOOK
      • EARMARK DATABASE
      • PRIME CUTS
      • ISSUE BRIEFS
      • AGENCY COMMENTS
    • DEFENSE
      • AVIATION & SPACE
      • F-35 JOINT STRIKE FIGHTER
      • PROCUREMENT
    • INNOVATION & TECHNOLOGY POLICY CENTER
      • ANTITRUST
      • ARTIFICIAL INTELLIGENCE
      • BIOPHARMACEUTICALS
      • INTELLECTUAL PROPERTY
      • PRIVACY
      • TECHNOLOGY AND INNOVATION
      • TELECOMMUNICATIONS
    • GENERAL WASTE
      • AGRICULTURE REFORM
      • POSTAL SERVICE
      • TAXES
      • TRANSPORTATION
    • HEALTH AND SCIENCE
      • PRICE CONTROLS
      • GOVERNMENT RUN HEALTHCARE
      • 340B DRUG DISCOUNT PROGRAM
      • PHARMACY BENEFIT MANAGERS
      • TOBACCO HARM REDUCTION
    • STATE ISSUES
  • ITPC
        • ANTITRUST
        • ARTIFICIAL INTELLIGENCE
        • BIOPHARMACEUTICALS
        • INTELLECTUAL PROPERTY
        • PRIVACY
        • TECHNOLOGY AND INNOVATION
        • TELECOMMUNICATIONS
  • CCAGW
DONATE
Facebook X-twitter Icon-instagram-1 Icon-youtube

Intellectual Property

Intellectual Property, Technology

In a World of AI, Intellectual Property Rights Must Be Protected

April 25, 2025 Deborah Collier

World Intellectual Property (IP) Day is always an opportunity to reiterate the significance of the only property right protected in the Constitution.  Celebrated every April 26, the festivities home in on a particular aspect of IP.  The 2025 theme is “IP and Music:  Feel the beat of IP.” Every nation has its own beat and […]

340B, Biopharmaceuticals, General Waste, Healthcare, Intellectual Property, International

Implementation of Drug Pricing EO Should Protect Innovation and IP

April 16, 2025 Thomas Schatz

President Trump’s EO addresses the dual objectives of lowering drug prices while promoting innovation and protecting IP

The Biden-Harris Administration’s Unintelligent Attack on AI
Antitrust, Commerce, Housing, Intellectual Property, Oversight, Regulations, Technology, Telecommunications

The Biden-Harris Administration’s Unintelligent Attack on AI

October 16, 2024 Deborah Collier

The Biden-Harris administration’s latest attack on American innovation is aimed at artificial intelligence.

Protecting Intellectual Property in an AI World
Commerce, Intellectual Property, Technology, Telecommunications

Protecting Intellectual Property in an AI World

September 11, 2024 Deborah Collier

Intellectual property rights should be protected when artificial intelligence is used in creative works.

USPTO-FDA Study Debunks Critics and Demonstrates the Importance of Protecting IP
Healthcare, Intellectual Property, Pharmaceuticals

USPTO-FDA Study Debunks Critics and Demonstrates the Importance of Protecting IP

September 6, 2024 Deborah Collier

USPTO-FDA study reinforces the need to protect pharmaceutical intellectual property rights for the future of new drug development.

Recognizing and Protecting Medical Invention and Innovation on World IP Day
General Waste, Intellectual Property

Recognizing and Protecting Medical Invention and Innovation on World IP Day

April 26, 2024 Christina Smith

There is nothing more important to strengthening innovation than protecting and promoting intellectual property in healthcare.

General Waste, Healthcare, Intellectual Property, International, Pharmaceuticals, States

FDA Hurts Patients By Authorizing Florida’s Drug Importation Program

January 12, 2024 Christina Smith

On January 5, 2024, the U.S. FDA authorized Florida’s drug importation program. 

General Waste, Healthcare, Intellectual Property, Pharmaceuticals

Misguided Use of March-In Rights Will Harm Patients

December 6, 2023 Christina Smith

The use of march-in rights to steal intellectual property will neither lower costs nor create more access to healthcare.

General Waste, Healthcare, Intellectual Property, Medicare, Pharmaceuticals

Biden Price Controls Kill Innovation and Patients

October 6, 2023 Christina Smith

 IRA drug price controls will devastate future drug development, resulting in more lives lost.

Biopharmaceuticals, General Waste, Healthcare, Intellectual Property, Pharmaceuticals, Regulations

Biden’s Budget and the SMART Prices Act Will Devastate Drug Development

June 24, 2023 Thomas Schatz

Pharmaceutical price controls in President Biden’s budget and the SMART Choices Act will devastate drug development.

Posts pagination

1 2 … 8 Next

Search

Citizens Against Government Waste works to eliminate waste, fraud, abuse, and mismanagement in government through research and public education.

  • ABOUT
  • WASTEWATCHER
  • MEDIA CENTER
  • ISSUES
  • ITPC
  • CCAGW
  • 1-800-USA-DEBT ®
  • MEDIA@CAGW.ORG
  • 317 MASSACHUSETTS AVENUE, N.E.
    SUITE 300
    WASHINGTON, D.C. 20002

© Citizens Against Government Waste